Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/7/2019
SIETES contiene 92793 citas

 
 
 1 a 20 de 33 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ 2018;361:23 de mayo. [Ref.ID 102648]
2. Cita con resumen
Anónimo. QT interval and drug therapy. Drug Ther Bull 2016;54:33-6. [Ref.ID 100134]
5.Tiene citas relacionadas Cita con resumen
Shin J-Y, Park M-J, Lee SH, Choi S-H, Kim M-H, Choi N-K, Lee J, Park B-J. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ 2015;351:h3517. [Ref.ID 99249]
6. Cita con resumen
Anónimo. Patientes enceintes migraineuses. Prescrire 2014;34:356-7. [Ref.ID 97565]
7.Enlace a cita original Cita con resumen
Carvajal A, Ortega S, Del Olmo L, Vidal X, Aguirre C, Ruiz B, Conforti A, Leone R, López-Vázquez P, Figueiras A, Ibáñez L. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study. PLoS One 2011;6:e19819. [Ref.ID 90662]
8.Tiene citas relacionadas Cita con resumen
Martinez C, Assimes TL, Mines D, Dell'Aniello S, Suissa S. Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ 2010;340:352. [Ref.ID 87828]
9.Tiene citas relacionadas
Taylor D. Venlafaxine and cardiovascular toxicity. BMJ 2010;340:327. [Ref.ID 87826]
10. Cita con resumen
Anónimo. Dosulepin. Measures to reduce risk of fatal overdose. UK. WHO Pharmaceuticals Newsletter 2008;1:6. [Ref.ID 82670]
11.Tiene citas relacionadas
Smith DJ, Walters JT. Bipolarity is important during treatment with antidepressants. BMJ 2007;334:327. [Ref.ID 79340]
12.Enlace a cita originalTiene citas relacionadas Cita con resumen
Cipriani A, Geddes JR, Barbui C. Venlafaxine for major depression. BMJ 2007;334:215-6. [Ref.ID 79088]
14.
Mann JJ. The medical management of depression. N Engl J Med 2005;353:1819-34. [Ref.ID 75204]
15. Cita con resumen
Anónimo. ADRs account for £500 million of NHS costs. Scrip 2004;2969:2-3. [Ref.ID 70878]
16.Tiene citas relacionadas
Wessely S, Kerwin R. Suicide risk and the SSRIs. JAMA 2004;292:379-81. [Ref.ID 70789]
17.Tiene citas relacionadas Cita con resumen
Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA 2004;292:338-43. [Ref.ID 70784]
18. Cita con resumen
Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653-61. [Ref.ID 65123]
20. Cita con resumen
Hippisley-Cox J, Pringle M, Hammersley V, Crown N, Wynn A, Meal A, Coupland C. Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ 2001;323:666-9. [Ref.ID 59214]
Seleccionar todas
 
 1 a 20 de 33 siguiente >>